CW

CW Total Non-Current Assets

$3.22BQuarterly · USD

Period ending:

CW FY Non-Current AssetsUSD
CW FY Non-Current Assets1989-12-31: $114.80M1990-12-31: $136.60M1991-12-31: $118.90M1992-12-31: $114.80M1993-12-31: $100.70M1994-12-31: $94.40M1995-12-31: $92.60M1996-12-31: $109.40M1997-12-31: $113.30M1998-12-31: $154.10M1999-12-31: $206.70M2000-12-31: $207.34M2001-12-31: $274.47M2002-12-31: $511.24M2003-12-31: $599.14M2004-12-31: $869.19M2005-12-31: $909.82M2006-12-31: $969.51M2007-12-31: $1.23B2008-12-31: $1.24B2009-12-31: $1.30B2010-12-31: $1.34B2011-12-31: $1.49B2012-12-31: $1.94B2013-12-31: $2.12B2014-12-31: $1.83B2015-12-31: $1.71B2016-12-31: $1.62B2017-12-31: $1.83B2018-12-31: $1.91B2019-12-31: $2.23B2020-12-31: $2.72B2021-12-31: $2.80B2022-12-31: $2.93B2023-12-31: $2.90B2024-12-31: $3.14B2025-12-31: $3.20B$3.20B$0.00
1989-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CW total non-current assets history

Long-term assets expected to provide value beyond one year. The available annual fiscal periods series contains 37 observations from Dec 31, 1989 to Dec 31, 2025.

Curtiss-Wright Corporation Common Stock Total Non-Current Assets — Annual fiscal periods (USD)
Period endingTotal Non-Current Assets (USD)
3,202,818,000
3,136,110,000
2,903,889,000
2,932,289,000
2,795,737,000
2,720,510,000
2,234,470,000
1,911,419,000
1,834,461,000
1,622,970,000
1,712,758,000
1,828,436,000
2,120,991,000
1,938,827,000
1,485,703,000
1,341,991,000
1,304,540,000
1,240,011,000
1,227,379,000
969,511,000
909,819,000
869,186,000
599,142,000
511,238,000
274,471,000
207,344,000
206,700,000
154,100,000
113,300,000
109,400,000
92,600,000
94,400,000
100,700,000
114,800,000
118,900,000
136,600,000
114,800,000

Compare total non-current assets

All CW financial metrics · CW stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.